In conclusion, human genetic data coupled with in vivo and in vitro experiments clearly indicate a critical role of BRSK2 in regulating GSIS function, subsequent systematic insulin resistance, and T2DM through crosstalk between β cells and insulin target tissues. The gene discussed is INS; the disease is Insulin resistance.